Association Between DLCO and Echocardiographic Right Ventricular–Pulmonary Arterial Coupling in Idiopathic Pulmonary Fibrosis
Authors:
- Francesca CoppiFCFrancesca Coppi
- Susan DarroudiSusan Darroudi
- Giulia RendaGRGiulia Renda
- Alessandra LodesertoALAlessandra Lodeserto
- Arianna MainiAMArianna Maini
- Damiano De CesareDCDamiano De Cesare
- Youssef OthmanYoussef Othman
- Martina MercatiMMMartina Mercati
- Dalia CaleffiDCDalia Caleffi
- Filippo GozziFGFilippo Gozzi
- Francesco MarangiFMFrancesco Marangi
- Dario AndrisaniDADario Andrisani
Open Access
- 3 September 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6833
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is frequently complicated by pulmonary vascular involvement and right ventricular (RV) dysfunction, both of which adversely affect prognosis. The relationship between impaired gas exchange and echocardiographic indices of RV function, particularly the TAPSE/PAPs (tricuspid annular plane systolic excursion/systolic pulmonary artery pressure) ratio as a marker of RV–pulmonary arterial (RV–PA) coupling, has not been fully characterized. Methods: We retrospectively evaluated 198 consecutive patients with IPF assessed at a single tertiary referral center between 2020 and 2026; 188 with complete pulmonary function testing were included in the main analyses. The primary exposure was gas exchange, measured by single-breath DLCO% (diffusing capacity of the lung for carbon monoxide) and stratified into four categories (Normal ≥ 80%, n = 21; Mild 60–79%, n = 56; Moderate 40–59%, n = 70; Severe < 40%, n = 41). The main outcome measures were echocardiographic indices of RV function—TAPSE, systolic pulmonary artery pressure (PAPs), and the TAPSE/PAPs ratio. Associations were assessed using Pearson’s correlation, one-way ANOVA, and multivariable linear regression adjusted for age, sex, and smoking status, with the Mild group as the reference for categorical analyses. Results: Lower DLCO values were independently associated with higher PAPs (adjusted β = −0.24 mmHg per 1% DLCO, p = 0.004) and with a lower TAPSE/PAPs ratio (adjusted β = +0.005 per 1% DLCO, p = 0.040). Compared with the Mild reference group, patients with Severe DLCO reduction had markedly higher PAPs (+14.6 mmHg, p = 0.002) and a lower TAPSE/PAPs ratio (−0.37, p = 0.002), with attenuated findings in the Moderate category; the small Normal group did not differ significantly from the Mild one. TAPSE alone showed only a weak, non-significant trend (r = 0.195, p = 0.083). Conclusions: In patients with IPF, lower DLCO was independently associated with higher pulmonary artery pressure and, to a lesser extent, with reduced RV–PA coupling (a lower TAPSE/PAPs ratio), whereas RV longitudinal systolic function (TAPSE) appeared preserved. Among pulmonary function parameters, DLCO showed the strongest association with PAPs. In this exploratory, cross-sectional analysis, combined evaluation of DLCO and the TAPSE/PAPs ratio may help characterize right heart involvement in IPF; its value for pulmonary hypertension (PH) screening requires prospective confirmation.Keywords
This publication has 40 references indexed in Scilit:
- Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyAdvances in Therapy, 2026
- Echocardiographic Evaluation of Pulmonary Hypertension: A Contemporary Review of the American Society of Echocardiography (ASE) Guidelines and Emerging ModalitiesCurrent Cardiology Reports, 2025
- Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasisDevelopmental Cell, 2025
- Pulmonary hypertension in patients with Sjögren's syndrome: Gender differences in cardiovascular risk factors and instrumental dataInternational Journal of Cardiology, 2025
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2025
- The Echocardiographic Evaluation of the Right Heart: Current and Future AdvancesCurrent Cardiology Reports, 2023
- Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORDThe Journal of Heart and Lung Transplantation, 2023
- Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative ReviewPulmonary Therapy, 2023
- Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary HypertensionPulmonary Circulation, 2022
- Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary FibrosisChest, 2019